Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
U
6973
vs
T
Taiwan Weighted Index
Over the past 12 months, U-Neuron Biomedical Inc has underperformed Taiwan Weighted Index, delivering a return of +44% compared to Taiwan Weighted Index's +60% growth.
Stocks Performance
6973 vs Taiwan Weighted Index
Performance Gap
6973 vs Taiwan Weighted Index
Performance By Year
6973 vs Taiwan Weighted Index
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
U-Neuron Biomedical Inc
Glance View
U-Neuron Biomedical, Inc. engages in the research and development of stem cell storage and separation technology, and treatment application technology. The company is headquartered in Taipei, New Taipei. The company went IPO on 2023-07-20. In the part of new drug development, allogeneic amniotic fluid stem cells and their derivatives are used as the main body, and the excellent regeneration ability of amniotic fluid stem cells is used to develop a variety of suitable applications. In the part of cosmetics and health care consumer products, a series of medical beauty and health care products have been developed with deer amniotic fluid stem cell derivatives as the main axis. The new drug development products include UA002 for the treatment of erectile dysfunction and UB003 for the treatment of dry eye. The cosmetics and health care consumer products include masks, essences, and creams for anti-aging, repairing and moisturizing, moisturizing and translucent. The products are mainly sold domestically.